Congenital anomalies surveillance in Canada.
Congenital anomalies (CA) are present in approximately 3% of all newborn babies and account for about 12% of paediatric hospital admissions. They represent an important public health problem. Surveillance is especially important so that preventive measures such as folic acid fortification can be properly assessed without resorting to a series of ad hoc studies. Canada's surveillance of CAs is weak, with only Alberta and British Columbia having established sytems. Most provinces have perinatal systems but their CA data are incomplete and they do not capture terminations of pregnancy. The same is true of the Public Health Agency of Canada's system. A new system, the Fetal Alert Network, has been proposed for Ontario, which represents a start but will require additional sources of ascertainment if it is to be a truly population-based system for Ontario.
Lowry
R Brian
RB
Alberta Congenital Anomalies Surveillance System, Alberta Health & Wellness, Department of Medical Genetics, University of Calgary, Calgary, AB. brian.lowry@calgaryhealthregion.ca
D002170:Canada / Q000453:epidemiology; D000013:Congenital Abnormalities / Q000453:epidemiology* / Q000517:prevention & control; D003628:Database Management Systems; D005260:Female; D006761:Hospitals; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009313:National Health Programs; D018743:Perinatal Care; D011159:Population Surveillance / Q000379:methods*; D011247:Pregnancy; D015995:Prevalence; D040442:Public Health Informatics; D012042:Registries